Do We Have Evidence for Predictive Biomarkers for Major Depressive Disorder?: A Meta-Analysis and Systematic Review of Prospective Studies

Publication date

2018-05-01

Authors

Kennis, MitzyISNI 0000000443375339
Gerritsen, LotteISNI 0000000397191300
van Dalen, M.ISNI 0000000507736990
Williams, A.D.ISNI 0000000506297535
Cuijpers, P.
Bockting, Claudi L.ISNI 0000000390535502

Editors

Advisors

Supervisors

Document Type

Abstract

License

Abstract

Background During the last century many biological hypotheses have been postulated to underlie the psychopathology of major depressive disorder (MDD). In order to gain insight in the evidence for these hypothesis from patients, a systematical search for longitudinal studies investigating biological factors before the onset of MDD was performed. Methods PubMed, PsychINFO, and Embase were used as databases. The search strategy included terms relating to (1) MDD; (2) a longitudinal design or onset/relapse/recurrence; and (3) potential biomarkers. Current leading biological models for depression were covered, including neuroimaging, neurotransmitters, neurotrophic factors, hormones and immunology. Results PRISMA guidelines were followed and 46830 articles were initially screened, indication 642 relevant articles that were screened on full text. Eventually, 90 articles fulfilled the inclusion criteria. Results were too heterogeneous or limited to perform meta-analyses for the topics: Neuroimaging (n=19), Gut (n=1), Immunology/inflammation (n=5), Neurotrophic (n=1), Neurotransmitters (n=1), Hormones (n=62), Oxidative stress (n=1). A meta analysis was performed for cortisol, which showed that higher cortisol levels predict a 44% higher chance of developing MDD (n=14, OR: 1.44 [1.12-1.84] p = 0.004), but not having a relapse or recurrent episode (n=4, OR: 1.524 [0.801 2.899] p=0.199). Conclusions Surprisingly, although a rigorous systematic search for prospective evidence for biomarkers for depression was performed, we found limited prospective studies investigating leading biological models. Only cortisol could be identified as prospective biomarker for depression onset. More prospective studies are necessary to investigate the causes (and consequences) of depression onset, relapse and recurrence. Supported By NIAS: Netherlands Institute For Advanced Study in the Humanities and Social Sciences (grant for Claudi Bocktings group)

Keywords

Major Depression, Meta-analysis, Neuroendocrinology, Cortisol, Neuroimaging

Citation

Kennis, M, Gerritsen, L, van Dalen, M, Williams, A D, Cuijpers, P & Bockting, C L H 2018, 'Do We Have Evidence for Predictive Biomarkers for Major Depressive Disorder? A Meta-Analysis and Systematic Review of Prospective Studies', Biological Psychiatry, vol. 83, no. 9, pp. S186. https://doi.org/10.1016/j.biopsych.2018.02.486